Use of Activated Recombinant FVII in Spinal Surgery

Clinical trial NCT00102037 · COMPLETED

Trial details

NCT number: NCT00102037
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Spinal Fusion

Start date: 2004-07-01
Primary completion: 2006-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.